Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases
- PMID: 33125722
- DOI: 10.1111/ajd.13491
Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases
Abstract
Background: Histiocytoses are haematological disorders of bone marrow origin that share many biological and clinical features with haematological neoplasms. The association between histiocytoses of the cutaneous-group and myeloid malignancies is a poorly investigated topic of high biological and clinical impact.
Methods: We performed a systematic review of the scientific literature, compliant with PRISMA guidelines, to unravel the clinical and pathological features of this intriguing association.
Findings: We gathered and analysed 102 patients. Most were children with generalised cutaneous eruptions and displayed risk organ involvement (i.e. bone marrow, spleen, liver). Interestingly, all these features are uncommonly encountered in C-group histiocytosis not associated with haematological neoplasms.
Conclusions: Our review shows that generalised eruptions and risk organ involvement in cutaneous-group histiocytosis should raise a suspicion for a concomitant myeloid neoplasm both in children and in adults and warrant further investigations. A rapid recognition of this association is required to start a prompt and effective therapeutic management given the aggressive behaviour of the associated myeloid neoplasm in most instances.
Keywords: association; histiocytoses; leukaemia cutis; myeloid neoplasms; systematic review.
© 2020 The Australasian College of Dermatologists.
References
-
- Classen CF, Minkov M, Lehrnbecher T. The non -langerhans cell histiocytoses (Rare Histiocytoses) - clinical aspects and therapeutic approaches. Klin. Padiatr. 2016; 228: 294-306.
-
- Haroche J, Cohen-Aubart F, Rollins BJ et al. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol. 2017; 18: e113-25.
-
- Emile JF, Abla O, Fraitag S et al. Revised classification of histiocytoses and neoplasms of the macrophage -dendritic cell lineages. Blood 2016; 127: 2672-81.
-
- Berres M-L, Allen CE, Merad M. Pathological consequences of misguided dendritic cell differentiation in histiocytic diseases. Adv. Immunol. 2013; 120: 127-61.
-
- Durham BH, Lopez Rodrigo E, Picarsic J et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat. Med. 2019; 25: 1839-42.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical